4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-16-003108
Options or other derivatives
- Chief Financial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| O'Donnell Edward Chief Financial Officer | 2016-01-28 | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/form410211002_01282016.xml…